Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 31-40 of 50 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2010Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the diamond studyDent, J.; Vakil, N.; Jones, R.; Bytzer, P.; Schnoning, U.; Halling, K.; Junghard, O.; Lind, T.
2010Prevalence and correlates of shoulder pain and stiffness in a population-based study: the North West Adelaide Health StudyHill, C.; Gill, T.; Shanahan, E.; Taylor, A.
2010Long-term prognostic significance of early molecular response to imatinib in newly diagnosed chronic myeloid leukemia: an analysis from the International Randomized Study of Interferon and STI571 (IRIS)Hughes, T.; Hochhaus, A.; Branford, S.; Muller, M.; Kaeda, J.; Foroni, L.; Druker, B.; Guilhot, F.; Larson, R.; O'Brien, S.; Rudoltz, M.; Mone, M.; Wehrle, E.; Modur, V.; Goldman, J.; Radich, J.
2010Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancerPeeters, M.; Price, T.; Cervantes, A.; Sobrero, A.; Ducreux, M.; Hotko, Y.; Andre, T.; Chan, E.; Lordick, F.; Punt, C.; Strickland, A.; Wilson, G.; Ciuleanu, T.; Roman, L.; Van Cutsem, E.; Tzekova, V.; Collins, S.; Oliner, K.; Rong, A.; Gansert, J.
2010Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: results of the Australasian gastrointestinal trials group randomized phase III MAX studyTebbutt, N.; Wilson, K.; Gebski, V.; Cummins, M.; Zannino, D.; van Hazel, G.; Robinson, B.; Broad, A.; Ganju, V.; Ackland, S.; Forgeson, G.; Cunningham, D.; Saunders, M.; Stockler, M.; Chua, Y.; Zalcberg, J.; Simes, R.; Price, T.
2010Sampling and coverage issues of telephone surveys used for collecting health information in Australia: results from a face-to-face survey from 1999 to 2008DalGrande, E.; Taylor, A.
2010Multimorbidity - not just an older person's issue. Results from an Australian biomedical studyTaylor, A.; Price, K.; Gill, T.; Adams, R.; Pilkington, R.; Carrangis, N.; Shi, Z.; Wilson, D.
2010Baseline factors predictive of serious suicidality at follow-up: findings focussing on age and gender from a community-based studyFairweather-Schmidt, A.; Anstey, K.; Salim, A.; Rodgers, B.
2010Assessment of atrial septal defects in adults comparing cardiovascular magnetic resonance with transoesophageal echocardiographyTeo, K.; Disney, P.; Dundon, B.; Worthley, M.; Brown, M.; Sanders, P.; Worthley, S.
2010Phase III, randomized, open-label study of daily Imatinib Mesylate 400 mg versus 800 mg in patients with newly diagnosed, previously untreated chronic myeloid leukemia in chronic phase using molecular end points: Tyrosine Kinase Inhibitor Optimization and Selectivity StudyCortes, A.; Baccarani, M.; Guilhot, F.; Druker, B.; Branford, S.; Kim, D.; Pane, F.; Pasquini, R.; Goldberg, S.; Kalaycio, M.; Moiraghi, B.; Rowe, J.; Tothova, E.; de Souza, C.; Rudoltz, M.; Yu, R.; Krahnke, T.; Kantarjian, H.; Radich, J.; Hughes, T.